title: Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptor.
abstract: BACKGROUND
  The insulin-like growth factor-I (IGFI) receptor is a potential target for breast cancer treatment and may be influenced by dietary intake.
  
  
  METHODS
  Nested, case-control study of 265 postmenopausal breast cancer survivors; primary breast cancer tissue was stained to determine IGFI receptor status. Change in carbohydrate intake from baseline to year 1 of study was estimated from 24-hour dietary recalls. Breast cancer recurrence cases (91) were matched to two controls (n = 174) on disease and study characteristics and counter matched on change in carbohydrate intake. Weighted conditional logistic regression models fit the risk of recurrence on IGFI receptor status and dietary change.
  
  
  RESULTS
  Half of the tumors were IGFI receptor positive. Increased risk of recurrence was associated with IGFI receptor-positive status [HR 1.7; 95% confidence interval (CI), 1.2-2.5] and, separately, with a stable/increased intake of carbohydrates (HR 2.0; 95% CI, 1.3-5.0). There was a borderline significant interaction between those two variables (P = 0.11). Specifically, carbohydrate intake had no significant impact on risk of recurrence among women who were receptor negative, yet increased the risk of recurrence by more than 5-fold among women who were receptor positive (HR 5.5; 95% CI, 1.8-16.3).
  
  
  CONCLUSIONS
  Among women whose tumor tissue is positive for the IGFI receptor, reducing carbohydrate intake after diagnosis could reduce the risk of breast cancer recurrence. These findings need replication in a larger sample.
  
  
  CONCLUSIONS
  This is the first study to suggest that it may be possible to personalize dietary recommendations for breast cancer survivors based on molecular characteristics of their primary tumor tissue. .
authors.affiliation: Authors' Affiliations: Cancer Prevention and Control Program, Moores UCSD Cancer Center, Department of Family and Preventive Medicine; and.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Emond
authors.affiliation: Authors' Affiliations: Cancer Prevention and Control Program, Moores UCSD Cancer Center, Department of Family and Preventive Medicine; and.
authors.forename: John P
authors.initials: JP
authors.lastname: Pierce
authors.affiliation: Authors' Affiliations: Cancer Prevention and Control Program, Moores UCSD Cancer Center, Department of Family and Preventive Medicine; and.
authors.forename: Loki
authors.initials: L
authors.lastname: Natarajan
authors.affiliation: Authors' Affiliations: Cancer Prevention and Control Program, Moores UCSD Cancer Center, Department of Family and Preventive Medicine; and.
authors.forename: Laarni R
authors.initials: LR
authors.lastname: Gapuz
authors.affiliation: Authors' Affiliations: Cancer Prevention and Control Program, Moores UCSD Cancer Center, Department of Family and Preventive Medicine; and.
authors.forename: John
authors.initials: J
authors.lastname: Nguyen
authors.affiliation: Authors' Affiliations: Cancer Prevention and Control Program, Moores UCSD Cancer Center, Department of Family and Preventive Medicine; and.
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Parker
authors.affiliation: Department of Pathology, University of California, San Diego, La Jolla, California.
authors.forename: Nissi M
authors.initials: NM
authors.lastname: Varki
authors.affiliation: Authors' Affiliations: Cancer Prevention and Control Program, Moores UCSD Cancer Center, Department of Family and Preventive Medicine; and repatterson@ucsd.edu.
authors.forename: Ruth E
authors.initials: RE
authors.lastname: Patterson
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology / Q000378:metabolism / Q000473:pathology*; D016022:Case-Control Studies; D004040:Dietary Carbohydrates; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000378:metabolism; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D012307:Risk Factors; D017741:Survivors
chemical_list: D004040:Dietary Carbohydrates; D017526:Receptor, IGF Type 1
references.citation: JAMA. 2007 Jul 18;298(3):289-98
references.pmid: 17635889
references.citation: Control Clin Trials. 2002 Dec;23(6):728-56
references.pmid: 12505249
references.citation: Am J Epidemiol. 2012 Aug 15;176(4):347-56
references.pmid: 22842721
references.citation: Int J Epidemiol. 2006 Aug;35(4):1011-21
references.pmid: 16672309
references.citation: Nat Rev Cancer. 2012 Feb 16;12(3):159-69
references.pmid: 22337149
references.citation: J Acad Nutr Diet. 2013 Feb;113(2):288-96
references.pmid: 23127511
references.citation: Cancer Res. 1997 Aug 1;57(15):3079-83
references.pmid: 9242428
references.citation: BMC Cancer. 2013 Jun 19;13:297
references.pmid: 23777562
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2826-8
references.pmid: 16364996
references.citation: J Am Diet Assoc. 2005 Mar;105(3):382-91; quiz 488
references.pmid: 15746825
references.citation: Arch Intern Med. 2003 Jan 13;163(1):49-56
references.pmid: 12523916
references.citation: Ann Oncol. 2011 Jan;22(1):68-73
references.pmid: 20647220
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683
references.citation: J Clin Oncol. 2012 Jan 10;30(2):164-71
references.pmid: 22162568
references.citation: Breast Cancer Res. 2004;6(3):R199-214
references.pmid: 15084244
references.citation: Int J Epidemiol. 2004 Jun;33(3):485-92
references.pmid: 15105408
references.citation: Growth Horm IGF Res. 2010 Jun;20(3):245-54
references.pmid: 20347606
references.citation: Cancer Res. 2004 Jan 1;64(1):286-91
references.pmid: 14729636
references.citation: Appl Immunohistochem Mol Morphol. 2011 May;19(3):218-25
references.pmid: 21217522
references.citation: Cancer Res. 2008 Dec 15;68(24):10238-46
references.pmid: 19074892
references.citation: Cancer Lett. 2003 Jun 10;195(2):127-37
references.pmid: 12767520
references.citation: Oncol Rep. 2010 Apr;23(4):989-95
references.pmid: 20204283
references.citation: Endocr Pract. 2013 Jul-Aug;19(4):675-93
references.pmid: 23978590
references.citation: Int J Epidemiol. 2006 Aug;35(4):1022-4
references.pmid: 16931532
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):195-203
references.pmid: 16041870
references.citation: Mod Pathol. 2011 Feb;24(2):201-8
references.pmid: 21057462
references.citation: Eur J Cancer. 1994;30A(3):307-11
references.pmid: 8204350
references.citation: J Natl Cancer Inst. 2006 Dec 20;98(24):1767-76
references.pmid: 17179478
references.citation: Breast. 2013 Dec;22(6):1155-60
references.pmid: 23968866
references.citation: J Natl Cancer Inst. 2000 Sep 20;92(18):1472-89
references.pmid: 10995803
references.citation: Am J Clin Nutr. 2010 Sep;92(3):634-43
references.pmid: 20573797
references.citation: Int J Cancer. 2000 Nov 20;89(6):506-13
references.pmid: 11102895